Maebe It’s Maebelline

As we all know, thanks to the support of the good people of Tumblr, Tylenol has experienced a meteoric rise to second place. Even though her competition is stiff, I believe in Tylenol's ability to go the distance.

But let's take a look at the competition:

Elmer seems to be a lovely boy. I have no qualms with Elmer, and think he would look fantastic on a beer can. But what about Elmer's campaigns? Who is the power behind the throne here, and how have they managed to find such breakout success on this competition?

A handful of wealthy donors are trying to buy this competition.

At the end of the day, all donations are good donations here. This is a charity event so every penny earned is going to help animals in need. But it's not lost on me that Elmer's current ranking is thanks entirely to a few individuals with the financial means to put their thumbs on the scale.

Tylenol's donors, comparatively, are small and numerous, mostly $1-10 donations from many passionate believers in what she stands for (autism and pain relief I think).

Overall, the donations tell a very different story than what the base ranking shows you. Elmer is held aloft by just 24 donors and bolstered by a few wealthy patrons, whereas Tylenol has won the hearts of literally hundreds of people. Even the current third place, Abby, owes her ranking to numerous small contributions rather than one or two large ones.

As a 19-year-old sophomore at Stanford, Elizabeth Holmes decided to transform diagnostic medicine so she dropped out of college and used her tuition money to start her own company, Theranos. Ten years later, Holmes, pictured here holding a micro-vial, is on the cutting edge of medical technology — her new blood testing method allows hundreds of tests to be run using only a few drops of blood. And, Holmes’ methods are cheaper, faster, more accurate, and less invasive than conventional methods which often require a separate vial of blood for every test. As Holmes told Wired.com earlier this year, “I started this company because I wanted to spend my life changing our health care system. When someone you love gets really sick, most of the time when you find out, it’s too late to be able to do something about it. It’s heartbreaking… We wanted to make actionable health information accessible to people everywhere at the time it matters most. That means two things: being able to detect conditions in time to do something about them and providing access to information that can empower people to improve their lives.”

She is featured as Forbes’ youngest self-made woman billionaire.

Her tests will revolutionize the public health world as we know it; Making diagnostic testing accessible and affordable for more people (and potentially saving Medicare and Medicaid ~$100 billion each over the next decade). (x)

She is a coauthor on 82 US and 189 foreign patent applications. (x)